Business Wire | Nov 10, 2020 07:00AM EST

Schrdinger to Present at Upcoming Investor Conferences

Nov. 10, 2020

NEW YORK--(BUSINESS WIRE)--Nov. 10, 2020--Schrdinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that members of the management team will participate in the upcoming virtual investor conferences in November and December.

Jefferies Virtual London Healthcare ConferenceFireside Chat on November 17, 2020 at 12:35 p.m. ET

3rd Annual Evercore ISI HealthCONx ConferenceFireside Chat on December 2, 2020 at 3:30 p.m. ET

BMO 2020 Growth & ESG ConferenceFireside Chat on December 8, 2020 at 3:00 p.m. ET

Live webcasts of the fireside chats can be accessed under "News & Events" in the investors section of Schrdinger's website https://ir.schrodinger.com/news-and-events/event-calendar. Archived replays will be available for 90 days following each event.

About Schrdinger

Schrdinger is transforming the way therapeutics and materials are discovered. Schrdinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrdinger's multidisciplinary drug discovery team also leverages its software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

Founded in 1990, Schrdinger has over 400 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com and follow us on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201110005213/en/

CONTACT: Media Contact: Stephanie Simon Ten Bridge Communications stephanie@tenbridgecommunications.com 617-581-9333

CONTACT: Investor Contact: Christina Tartaglia Stern IR, Inc. christina.tartaglia@sternir.com 212-362-1200